Evidence map›Paper›PMID 32241250›Full record

ArticleJournal of neurodevelopmental disorders2020

Correction to: Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity.

Leonard Abbeduto, Elizabeth Berry-Kravis, Audra Sterling, Stephanie Sherman, Jamie O Edgin, Andrea McDuffie, Anne Hoffmann, Debra Hamilton, Michael Nelson, Jeannie Aschkenasy and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neurodevelopmental disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Leonard AbbedutoUC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California, 2825 50th St. Davis, Sacramento, CA, 95817, USA. LJabbeduto@ucdavis.edu.
Elizabeth Berry-KravisDepartments of Pediatrics, Neurological Sciences and Biochemistry, Rush University Medical Center, Chicago, USA.
Audra SterlingWaisman Center and Department of Communication Sciences and Disorders, University of Wisconsin-Madison, Madison, USA.
Stephanie ShermanDepartment of Human Genetics, Emory University, Atlanta, USA.
Jamie O EdginDepartment of Psychology, University of Arizona, Tucson, USA.
Andrea McDuffieUC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California, 2825 50th St. Davis, Sacramento, CA, 95817, USA.
Anne HoffmannDepartments of Pediatrics, Neurological Sciences and Biochemistry, Rush University Medical Center, Chicago, USA.
Debra HamiltonDepartment of Human Genetics, Emory University, Atlanta, USA.
Michael NelsonDepartments of Pediatrics, Neurological Sciences and Biochemistry, Rush University Medical Center, Chicago, USA.
Jeannie AschkenasyDepartments of Pediatrics, Neurological Sciences and Biochemistry, Rush University Medical Center, Chicago, USA.
Angela John ThurmanUC Davis MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California, 2825 50th St. Davis, Sacramento, CA, 95817, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article [1], the author name Leonard Abbeduto was misspelled as Leonardkk Abbeduto. The original article has been corrected.

Identifiers

PMID32241250
PMCPMC7119274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.